$37.77
-$0.30
(-0.79%)
Quote as of 10:57 AM EST on 02/15/12
BioMarin Pharmaceutical
NASDAQ:BMRN
|
$37.77
-$0.30
(-0.79%)
|
|
| Today's Open | $38.20 |
|---|---|
| Previous Close | $38.07 |
| Daily Range | $37.58 - $38.20 |
| 52-Week Range | $23.09 - $38.95 |
| Market Cap | $4.31B |
| P/E Ratio | -152.28 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 88,460 |
| Average Daily Volume | 1,169,306 |
| Current FY EPS | -$0.34 |
BMRN Information
| Description |
|---|
| The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
BioMarin Pharmaceutical (BMRN) - Bear of the Day
Zacks Bull and Bear of the Day Highlights: ProAssurance, BioMarin Pharmaceutical, Diebold, Vodafone
Zacks #5 Rank Additions for Wednesday - Tale of the Tape
Don't Get Too Worked Up Over BioMarin Pharmaceutical's Earnings
Qiagen Expands with New Deals - Analyst Blog
JPMorgan Confab Kicks Off Biotech 2012
Too Early for a New Biotech Orphan?
BioMarin's Facility Expansion Backed - Analyst Blog
Pipeline Progress at BioMarin - Analyst Blog
